Ultomiris HI IV infusion 300mg/3mL, manufactured by Alexion Pharma, contains Ravulizumab (genetical recombination). This injectable drug (YJ code: 6399427A2023) is supplied as 300mg in 3mL per bottle. It is used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
Ultomiris HI IV infusion 300mg/3mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →